Randomized controlled study of gemcitabine plus S-1 combination chemotherapy versus gemcitabine for unresectable pancreatic cancer

被引：0
|
作者：
Kentaro Sudo
Takeshi Ishihara
Nobuto Hirata
Fumiaki Ozawa
Tadashi Ohshima
Ryosaku Azemoto
Kenji Shimura
Takeshi Nihei
Takayoshi Nishino
Akihiko Nakagawa
Kazuyoshi Nakamura
Taro Hara
Motohisa Tada
Rintaro Mikata
Katsunobu Tawada
Osamu Yokosuka
So Nakaji
Taketo Yamaguchi
机构：
[1] Chiba Cancer Center,Department of Gastroenterology
[2] Chiba University,Department of Gastroenterology and Nephrology, Graduate School of Medicine
[3] Kameda Medical Center,Department of Gastroenterology
[4] Saitama Medical University,Department of Hepato
[5] Saitama Red Cross Hospital,biliary
[6] Kimitsu Chuo Hospital,pancreatic Surgery, Saitama Medical Center
[7] Asahi General Hospital,Department of Gastroenterology
[8] Mito Saiseikai General Hospital,Department of Gastroenterology
[9] Tokyo Women’s Medical University Yachiyo Medical Center,Department of Gastroenterology
[10] Numazu City Hospital,Department of Internal Medicine
来源：
Cancer Chemotherapy and Pharmacology | 2014年 / 73卷
关键词：
Pancreatic cancer; S-1; Gemcitabine; Randomized controlled study;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：389 / 396
页数：7
相关论文
共 50 条
  • [31] RANDOMIZED PHASE II TRIAL OF S-1 VERSUS S-1 PLUS OXALIPLATIN (SOX) IN PATIENTS WITH GEMCITABINE REFRACTORY PANCREATIC CANCER
    Okusaka, T.
    Ohkawa, S.
    Isayama, H.
    Fukutomi, A.
    Yamaguchi, K.
    Ikeda, M.
    Funakoshi, A.
    Nagase, M.
    Nakamori, S.
    Hamamoto, Y.
    ANNALS OF ONCOLOGY, 2012, 23 : 241 - 242
  • [32] Gemcitabine plus S-1: a hopeful frontline treatment for Asian patients with unresectable advanced pancreatic cancer
    Cao, Chunxiang
    Kuang, Meng
    Xu, Wei
    Zhang, Xunlei
    Chen, Jinfei
    Tang, Cuiju
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 45 (12) : 1122 - 1130
  • [33] A randomized controlled trial of gemcitabine plus cisplatin versus gemcitabine alone in the treatment of metastatic pancreatic cancer
    Chao, Yee
    Wu, Chen-Yi
    Wang, Jack P.
    Lee, Rheun-Chuan
    Lee, Wei-Ping
    Li, Chung-Pin
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (03) : 637 - 642
  • [34] A randomized controlled trial of gemcitabine plus cisplatin versus gemcitabine alone in the treatment of metastatic pancreatic cancer
    Yee Chao
    Chen-Yi Wu
    Jack P. Wang
    Rheun-Chuan Lee
    Wei-Ping Lee
    Chung-Pin Li
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 637 - 642
  • [35] Cost-effectiveness analysis of gemcitabine, S-1 and gemcitabine plus S-1 for treatment of advanced pancreatic cancer based on GEST study
    Zhou, Jing
    Zhao, Rongce
    Wen, Feng
    Zhang, Pengfei
    Tang, Ruilei
    Du, Zedong
    He, Xiaofeng
    Zhang, Jian
    Li, Qiu
    MEDICAL ONCOLOGY, 2015, 32 (04)
  • [36] Cost-effectiveness analysis of gemcitabine, S-1 and gemcitabine plus S-1 for treatment of advanced pancreatic cancer based on GEST study
    Jing Zhou
    Rongce Zhao
    Feng Wen
    Pengfei Zhang
    Ruilei Tang
    Zedong Du
    Xiaofeng He
    Jian Zhang
    Qiu Li
    Medical Oncology, 2015, 32
  • [37] Comparison of adjuvant nab-paclitaxel plus gemcitabine, S-1 and gemcitabine chemotherapy for resectable pancreatic cancer: a real-world study
    Li, Haorui
    Guo, Yu
    Sun, Xugang
    Lu, Yang
    Chang, Shaofei
    Wang, Xiuchao
    Gao, Song
    Gao, Chuntao
    Zhao, Tiansuo
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [38] Randomized phase II trial of S-1 versus S-1 plus irinotecan (IRIS) in patients with gemcitabine-refractory pancreatic cancer
    Mizuno, Nobumasa
    Yamao, Kenji
    Komatsu, Yoshito
    Munakata, Masaki
    Ishiguro, Atsushi
    Yamaguchi, Taketo
    Ohkawa, Shinichi
    Kida, Mitsuhiro
    Ioka, Tatsuya
    Takeda, Koji
    Kudo, Toshihiro
    Kitano, Masayuki
    Iguchi, Haruo
    Tsuji, Akihito
    Ito, Tetsuhide
    Tanaka, Masao
    Furuse, Junji
    Hamada, Chikuma
    Sakata, Yuh
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [39] Chemotherapy in Pancreatic Cancer: Comparative Study of Gemcitabine, S-1, and FOLFIRINOX, Nab-Paclitaxel plus Gem
    Miyata, H.
    Yamago, H.
    Ueki, H.
    Nagamatsu, K.
    Iwasaki, R.
    PANCREAS, 2019, 48 (10) : 1492 - 1492
  • [40] Neoadjuvant Chemotherapy With Gemcitabine and S-1 for Locally Advanced Pancreatic Cancer
    Kin, T.
    Maguchi, H.
    Takahashi, K.
    Katanuma, A.
    Osanai, M.
    Yane, K.
    Ikarashi, S.
    Sen-yo, M.
    Minami, R.
    Sano, I.
    PANCREAS, 2014, 43 (08) : 1379 - 1379
12345